reported that 4-1BBL+ CAR-Ts (with CD28 as the costimulatory domain and CD3ζ as the activation domain) exhibited pronounced tumor eradication capacity, which was correlated with the induction of IRF7/IFNβ pathway in these cells (177). This evidence concerns the gene IFNB1 and neoplasm.